Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine
(By Ed Silverman for ST A T) T he latest battle over access to medicines is taking place in Ukraine,
Read More
Part D/Prescription Drugs
EpiPen maker under investigation for antitrust violations in New York
(By Ike Swetlitz for ST A T) N ew York Attorney General Eric T. Schneiderman is investigating Mylan Pharmaceuticals for
Read MoreGene therapy for sickle cell moves closer as scientists clear unexpected obstacle
(By Sharon Begley for ST A T) R esearchers have cleared the last scientific hurdle to a clinical trial of
Read MoreSaline Nose Spray Might Help Tame Severe Nosebleeds
(By Nancy Shute for NPR) Saline nose spray is becoming increasingly popular as a treatment for allergies and sinus problems.
Read MoreThe drug pricing crusader at the center of one of the nastiest fights of the election season
(By Rebecca Robbins for ST A T) L OS ANGELES — There’s nobody the drug companies are spending more to
Read MoreHHS accelerates development of mRNA-based Zika vaccine
(Source – www.hhs.gov) The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response
Read MoreAllergan CEO promises to limit price hikes on drugs in a bid to rebuild the ‘social contract’
(By Ed Silverman for ST A T) S eeking to deflect harsh criticism of the pharmaceutical industry, one chief executive
Read MoreThe secretive system for vetting cancer drug use needs an urgent overhaul
(By Ed Silverman for ST A T) I n the complicated world of medicine and money, the federal government relies
Read MoreEpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog
(By Sydney Lupkin for Kaiser Health News) Consumers and Congress members pushing for cheaper alternatives to the EpiPen and other
Read MoreHidden network of kratom devotees tries to keep the supplement safe — and legal
(By Eric Boodman for ST A T) W hen money is scarce, Margo Burton and her husband will go without
Read More